4
Changes in Ownership
Milestone Pharmaceuticals Inc. Filed Acc 0001771207-26-000002
Chief Commercial Officer sold 64,746 shares at an average $2.25 ($145,851)
- Chief Commercial Officer acquired 100,000 shares (grant or award)
- Chief Commercial Officer acquired 20,100 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Muller Lorenz Chief Commercial Officer | 2025-12-12 | Grant or award | +100,000 | 250,052 | D | ||
| Muller Lorenz Chief Commercial Officer | 2025-12-15 | Sale | −53,566 | $2.32 | $124,273 | 196,486 | D |
| Muller Lorenz Chief Commercial Officer | 2026-01-26 | Option exercise | +20,100 | 216,586 | D | ||
| Muller Lorenz Chief Commercial Officer | 2026-01-26 | Sale | −11,180 | $1.93 | $21,577 | 205,406 | D |
| Derivatives | |||||||
| Muller Lorenz Chief Commercial Officer | 2025-12-12 | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | D | ||
| Muller Lorenz Chief Commercial Officer | 2026-01-26 | Option exercise · Restricted Stock Units | −20,100 | 60,300 | D | ||
| Open-market sales · 64,746 sh · avg $2.25 · $145,851 | |||||||
Loading xslF345X05/form4-01282026_060105.xml…